Holen Sie sich die Stockscreener-App
0.6571
3.14%
0.02
Handel nachbörslich:
.67
0.0129
+1.96%
Schlusskurs vom Vortag:
$0.6371
Offen:
$0.8054
24-Stunden-Volumen:
91.38M
Relative Volume:
13.76
Marktkapitalisierung:
$21.41M
Einnahmen:
$950.10K
Nettoeinkommen (Verlust:
$-16.69M
KGV:
-0.7917
EPS:
-0.83
Netto-Cashflow:
$-15.16M
1W Leistung:
-7.33%
1M Leistung:
+4.29%
6M Leistung:
-43.35%
1J Leistung:
-47.85%
1-Tages-Spanne:
$0.62
$0.8793
1-Wochen-Bereich:
$0.603
$0.8793
52-Wochen-Spanne:
$0.3067
$1.80
Femasys Inc Stock (FEMY) Company Profile
Firmenname
Femasys Inc
Sektor
Telefon
770-500-3910
Adresse
3950 JOHNS CREEK COURT, SUWANEE
Vergleichen Sie FEMY mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
FEMY
Femasys Inc
|
0.6571 | 27.40M | 950.10K | -16.69M | -15.16M | -0.83 |
|
ISRG
Intuitive Surgical Inc
|
544.21 | 189.40B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
177.30 | 51.22B | 21.39B | 1.61B | 2.55B | 5.5609 |
|
ALC
Alcon Inc
|
73.88 | 36.53B | 10.03B | 1.07B | 1.39B | 2.1549 |
|
RMD
Resmed Inc
|
248.95 | 36.04B | 5.15B | 1.40B | 1.65B | 9.5082 |
|
WST
West Pharmaceutical Services Inc
|
279.78 | 20.29B | 2.96B | 487.70M | 344.00M | 6.6758 |
Femasys Inc Aktie (FEMY) Neueste Nachrichten
Is Femasys Inc. stock affected by interest rate hikesJuly 2025 Closing Moves & Proven Capital Preservation Tips - newser.com
Femasys Stock Sparks Retail Frenzy After FDA Clears Final Phase Of FemBloc Trial And $58M Financing - Stocktwits
Can Femasys Inc. stock reach $100 price targetIPO Watch & Accurate Entry and Exit Point Alerts - newser.com
Femasys Secures Fda Approval to Advance Final Fembloc Trial Phase and $12 Million Financing, with Potential to Reach $58 Million - MarketScreener
Femasys Inc. announced that it expects to receive $12 million in funding - MarketScreener
Femasys gets FDA OK for final FemBloc trial, secures $12M financing, stock surges - MSN
Femasys Receives FDA Approval for FemBloc Trial - TipRanks
Applying Elliott Wave Theory to Femasys Inc.Weekly Trend Recap & Free Weekly Watchlist of Top Performers - newser.com
Femasys Inc Secures FDA Approval for Final FemBloc Trial Phase - TradingView
FDA approves Femasys to continue pivotal trial for non-surgical birth control - Investing.com
Femasys secures FDA approval to advance final FemBloc trial phase - TipRanks
Femasys Inc. Advances FemBloc Toward FDA Approval with Successful Trial Completion and $12 Million Financing - Quiver Quantitative
Why Femasys Inc. stock is considered a top pickMarket Movement Recap & Expert Approved Momentum Ideas - newser.com
Femasys Secures FDA Approval to Advance Final FemBloc® Trial Phase and $12 Million Financing, ... - Caledonian Record
Femasys Secures FDA Approval to Advance Final FemBloc® - GlobeNewswire
Exit strategy if you’re trapped in Femasys Inc.2025 Breakouts & Breakdowns & Technical Pattern Based Signals - newser.com
Is Femasys Inc. stock a safe haven assetPortfolio Update Report & Long-Term Safe Investment Plans - newser.com
Is Femasys Inc. forming a bottoming base2025 Volatility Report & Long-Term Growth Stock Strategies - newser.com
Femasys Meets Nasdaq Equity Requirement After Offering - MSN
Custom watchlist performance reports with Femasys Inc.Earnings Overview Summary & Accurate Buy Signal Notifications - newser.com
Will Femasys Inc. stock continue upward momentum2025 Top Gainers & Daily Price Action Insights - newser.com
What margin trends mean for Femasys Inc. stockTrade Risk Report & Daily Profit Maximizing Tips - newser.com
What to do if you’re stuck in Femasys Inc.Quarterly Investment Review & Free Expert Approved Momentum Trade Ideas - newser.com
Will Femasys Inc. stock benefit from commodity pricesEntry Point & High Accuracy Trade Signal Alerts - newser.com
Is Femasys Inc. stock positioned well for digital economyPortfolio Update Summary & Consistent Profit Trading Strategies - newser.com
How institutional buying supports Femasys Inc. stockWeekly Stock Report & Risk Managed Investment Strategies - newser.com
Why Femasys Inc. stock is favored by pension fundsTrade Risk Report & Free Real-Time Volume Trigger Notifications - newser.com
Combining machine learning predictions for Femasys Inc.Stock Surge & Weekly High Return Stock Opportunities - newser.com
Applying Wyckoff theory to Femasys Inc. stockEarnings Risk Report & High Return Stock Watch Alerts - newser.com
Finanzdaten der Femasys Inc-Aktie (FEMY)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.41%
0.47%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):